Three major pharmaceutical companies just reported earnings — here's how they did

  • 📰 CNBC
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Singapore News News

Singapore Singapore Latest News,Singapore Singapore Headlines

Shares of pharmaceutical giants Pfizer and Merck rose in premarket trading after reporting first-quarter financial results that beat Wall Street's expectations.

rose more than 1% in premarket trading on Tuesday after reporting first-quarter financial results that beat Wall Street's expectations.dropped 3.0% after the company reported first-quarter earnings that topped expectations, but revenue that missed. Eli Lilly's key drugs Trulicity and Alimta fell short of Wall Street's forecasts.

Health care has been the worst-performing sector in the stock market this year on concerns of drug pricing reform and "Medicare for All" proposals from Democratic lawmakers. The Health Care Select Sector SPDR Fund, an ETF that tracks the health-care industry's biggest companies, has risen by just 2.7% as of Monday, significantly lagging the broader market indexes. The Dow Jones Industrial Average is up 13% over the same period, and the S&P 500 is 17% higher.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Did they sell out to earn

Shares of Pfizer rose after beating Wall Street estimates for both EPS and revenue.

Singapore Singapore Latest News, Singapore Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck shares rise premarket as earnings top estimatesMerck & Co. Inc. shares rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and...
Source: MarketWatch - 🏆 3. / 97 Read more »